Adoptive T-Cell Therapy of Melanoma Using Designer T-Cell Receptors Kim Margolin Clinical Trial Report 20 September 2011 Pages: 427 - 429
Treatment of Advanced Melanoma with Immunological Checkpoint Block Kim Margolin Clinical Trial Report 22 September 2011 Pages: 430 - 432
What is the Role of Chemotherapy in Endometrial Cancer? Thomas Hogberg Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 27 August 2011 Pages: 433 - 441
PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond Susana BanerjeeStan Kaye Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 14 September 2011 Pages: 442 - 449
Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era? Joyce LiuUrsula A. Matulonis Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 13 October 2011 Pages: 450 - 458
Recurrent Ovarian Cancer: When and How to Treat Marcia HallGordon Rustin Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) 03 November 2011 Pages: 459 - 471
The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends Carien L. CreutzbergRemi A. Nout Gynecologic Cancers (Jonathan A. Ledermann, Section Editor) Open access 16 August 2011 Pages: 472 - 478
The “SWOT” of BRAF Inhibition in Melanoma: RAF Inhibitors, MEK Inhibitors or Both? Moriah H. NissanDavid B. Solit Melanoma (Kim A. Margolin, Section Editor) 14 October 2011 Pages: 479 - 487
Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer Shailender BhatiaOlga AfanasievPaul Nghiem Melanoma (Kim Margolin, Section Editor) 28 September 2011 Pages: 488 - 497